Dicerna Pharmaceutic
(DRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 09-2012 | 12-2011 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | N/A | N/A | 22,490 |
| Receivables | N/A | N/A | 160 |
| Other current assets | 0 | 0 | 370 |
| TOTAL | $N/A | $N/A | $23,020 |
| Non-Current Assets | |||
| PPE Net | N/A | N/A | 2,630 |
| TOTAL | $N/A | $N/A | $2,630 |
| Total Assets | $N/A | $N/A | $24,630 |
| Liabilities | |||
| Current Liabilities | |||
| TOTAL | $N/A | $N/A | $5,290 |
| Non-Current Liabilities | |||
| Long Term Debt | N/A | N/A | 8,730 |
| Other Non-Current Liabilities | 0 | 0 | 790 |
| TOTAL | $N/A | $N/A | $9,520 |
| Total Liabilities | $N/A | $N/A | $15,110 |
| Shareholders' Equity | |||
| Retained earnings | N/A | N/A | -50,630 |
| Other shareholders' equity | 0 | 0 | 60,140 |
| TOTAL | $N/A | $N/A | $9,510 |
| Total Liabilities And Equity | $0 | $0 | $24,620 |